Pages that link to "Q77476844"
Jump to navigation
Jump to search
The following pages link to Unusual complications after bone marrow transplantation for dyskeratosis congenita (Q77476844):
Displaying 46 items.
- Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita (Q24536887) (← links)
- Genetic interstitial lung disease (Q24626239) (← links)
- Alternative donor transplant of benign primary hematologic disorders (Q26823398) (← links)
- Aplastic anemia in adolescents and young adults (Q26864775) (← links)
- The inherited bone marrow failure syndromes (Q26999046) (← links)
- Advances in unrelated and alternative donor hematopoietic cell transplantation for nonmalignant disorders (Q27022561) (← links)
- A spectrum of severe familial liver disorders associate with telomerase mutations (Q30913791) (← links)
- Nonmyeloablative allogeneic hematopoietic stem cell transplantation for treatment of Dyskeratosis congenita (Q33346928) (← links)
- Dyskeratosis congenita in a 40-year-old patient (Q33365577) (← links)
- Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia (Q33392788) (← links)
- Inherited bone marrow failure syndromes in adolescents and young adults (Q33415672) (← links)
- Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes (Q33430004) (← links)
- Syndromes of telomere shortening (Q33638357) (← links)
- Lung transplantation in telomerase mutation carriers with pulmonary fibrosis (Q33826806) (← links)
- Lung transplantation for pulmonary fibrosis in dyskeratosis congenita: Case Report and systematic literature review (Q33933652) (← links)
- Bone marrow failure and the telomeropathies (Q34431411) (← links)
- Short telomeres, even in the presence of telomerase, limit tissue renewal capacity (Q34563497) (← links)
- Cancer in dyskeratosis congenita (Q34605382) (← links)
- Constitutional telomerase mutations are genetic risk factors for cirrhosis (Q34862975) (← links)
- Low-intensity hematopoietic stem-cell transplantation across human leucocyte antigen barriers in dyskeratosis congenita (Q35128245) (← links)
- Dyskeratosis congenita: its link to telomerase and aplastic anaemia (Q35558515) (← links)
- Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita (Q35989413) (← links)
- Telomere diseases (Q36107376) (← links)
- Telomere maintenance and human bone marrow failure (Q36591289) (← links)
- Characterization of primitive hematopoietic cells from patients with dyskeratosis congenita (Q36591308) (← links)
- A Reduced-Intensity Conditioning Regimen for Patients with Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation (Q36782745) (← links)
- Hematopoietic stem cell transplantation in childhood inherited bone marrow failure syndrome (Q37033851) (← links)
- Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita (Q37077955) (← links)
- Genetic and environmental factors influencing human diseases with telomere dysfunction. (Q37285981) (← links)
- The genetics and clinical manifestations of telomere biology disorders (Q37300909) (← links)
- Fatal Hemorrhagic Gastrointestinal Angioectasia after Bone Marrow Transplantation for Dyskeratosis Congenita (Q37562747) (← links)
- Recent progress in dyskeratosis congenita (Q37794868) (← links)
- Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes (Q38520096) (← links)
- Transplantation for bone marrow failure: current issues (Q39027710) (← links)
- Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1/2 study (Q43281253) (← links)
- Successful umbilical cord blood transplantation in a child with dyskeratosis congenita after a fludarabine-based reduced-intensity conditioning regimen (Q44198087) (← links)
- Fludarabine, low-dose cyclophosphamide and rabbit antithymocyte globulin allowed stable engraftment after allogeneic peripheral blood stem cell transplantation for poly-transfused dyskeratosis congenita patient: case report (Q45800411) (← links)
- Reduced intensity conditioning is effective for hematopoietic SCT in dyskeratosis congenita-related BM failure. (Q46177519) (← links)
- Usual interstitial pneumonia complicating dyskeratosis congenita (Q47783078) (← links)
- Current Perspectives of Telomerase Structure and Function in Eukaryotes with Emerging Views on Telomerase in Human Parasites (Q48023136) (← links)
- Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita. (Q53330217) (← links)
- A reduced intensity conditioning regimen of fludarabine, cyclophosphamide, antithymocyte globulin, plus 2 Gy TBI facilitates successful hematopoietic cell engraftment in an adult with dyskeratosis congenita (Q63384262) (← links)
- Veno-occlusive disease of the liver after allogeneic bone marrow transplantation for severe aplastic anemia (Q73101628) (← links)
- Intensive immunosuppression therapy for aplastic anemia associated with dyskeratosis congenita: report of a case (Q81073729) (← links)
- Fatal diffuse capillaritis after hematopoietic stem-cell transplantation for dyskeratosis congenita despite low-intensity conditioning regimen (Q81311486) (← links)
- Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita (Q90485064) (← links)